Clinical Trial Update: Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose methotrexate in combination with I-131 labeled tositumomab for previously untreated advanced-stage follicular lymphoma; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• I-131 tositumomab (tositumomab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Follicular Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2016-07-12